Illumina News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

21.12.21	Form SC TO-I/A 1110803 (RSS)
24.11.21	Form 4 1110803 (RSS)
23.11.21	Form SC TO-I/A 1110803 (RSS)
04.11.21	Illumina Revises FY Guidance (RTTNews)
04.11.21	Illumina Inc. Q3 adjusted earnings Beat Estimates (RTTNews)
03.11.21	Ausblick: Illumina veröffentlicht Zahlen zum vergangenen Quartal (finanzen.net)
20.10.21	Erste Schätzungen: Illumina zieht Bilanz zum abgelaufenen Quartal (finanzen.net)
07.09.21	Illumina Partners With Merck To Develop Tests For Use In Identifying Specific Cancer Mutations (RTTNews)
20.08.21	European Commission To Assess Illumina's Possible Breach Of Standstill Obligation (RTTNews)
18.08.21	Illumina Acquires GRAIL to Accelerate Patient Access to Life-Saving Multi-Cancer Early-Detection Test (PR Newswire)
05.08.21	Illumina Inc. Q2 adjusted earnings Beat Estimates (RTTNews)
05.08.21	Illumina Reports Financial Results for Second Quarter of Fiscal Year 2021 (PR Newswire)
04.08.21	Illumina Donates $1 Million in Sequencing Capabilities to Mumbai to Support Sequencing-Based COVID-19 Surveillance in India (PR Newswire)
03.08.21	Ausblick: Illumina informiert über die jüngsten Quartalsergebnisse (finanzen.net)
21.07.21	Erste Schätzungen: Illumina stellt das Zahlenwerk zum vergangenen Quartal vor (finanzen.net)
01.06.21	Illumina Supports Nationwide Program across Belgium to Assess Whole Genome Sequencing for Developmental Disorders Diagnosis (Businesswire)
27.05.21	Illumina To Webcast Upcoming Investor Conference (Businesswire)
17.05.21	Illumina Appoints Susan Tousi as Chief Commercial Officer and Dr. Alex Aravanis as Chief Technology Officer, Head of Research and Product Development (Businesswire)
30.04.21	Illumina-Aktie: Das sind die Analysten-Einstufungen des vergangenen Monats (finanzen.net)
29.04.21	Illumina To Webcast Upcoming Investor Conference (Businesswire)
29.04.21	Illumina Files Action For Annulment Of EC's Decision Asserting Jurisdiction To Review GRAIL Deal (RTTNews)
29.04.21	Illumina Files Action for Annulment of European Commission’s Decision Asserting Jurisdiction to Review GRAIL Acquisition (Businesswire)
28.04.21	Illumina to Donate US $60 Million in Sequencing Capabilities to Establish a Global Pathogen Genomics Initiative (Businesswire)
27.04.21	Illumina Inc. Q1 adjusted earnings Beat Estimates (RTTNews)
27.04.21	Illumina Reports Financial Results for First Quarter of Fiscal Year 2021 (Businesswire)
25.04.21	Ausblick: Illumina zieht Bilanz zum jüngsten Jahresviertel (finanzen.net)
22.04.21	Illumina and Kartos Therapeutics Announce New Oncology Partnership to Develop an NGS-Based TP53 Companion Diagnostic (Businesswire)
20.04.21	Llumina Remains Committed To GRAIL Deal - Quick Facts (RTTNews)
20.04.21	Illumina Remains Committed to GRAIL Acquisition to Accelerate Access to Breakthrough Multi-Cancer Early Detection Blood Test (Businesswire)
14.04.21	Illumina, Inc. -- Moody's announces completion of a periodic review of ratings of Illumina, Inc. (Moodys)
12.04.21	Erste Schätzungen: Illumina gibt Ergebnis zum abgelaufenen Quartal bekannt (finanzen.net)
05.04.21	Illumina Announces Preliminary Revenue for First Quarter Fiscal Year 2021 (Businesswire)
31.03.21	Experten sehen bei Illumina-Aktie Potenzial (finanzen.net)
31.03.21	FTC Seeks To Block Illumina's Proposed $7.1 Bln Acquisition Of Grail (RTTNews)
30.03.21	Illumina Committed to Pursuing GRAIL Acquisition to Accelerate Access to Breakthrough Multi-Cancer Early Detection Blood Test (Businesswire)
18.03.21	Illumina Announces Board Changes (Businesswire)
16.03.21	Illumina, Inc. -- Moody's assigns Baa3 rating to Illumina's notes offering (Moodys)
11.03.21	Illumina and Harvard Pilgrim Health Care Real-World Evidence Study Demonstrates Cost-Effectiveness of Offering NIPT to All Pregnant Women (Businesswire)
10.03.21	Illumina, Inc. -- Moody's assigns a first-time Baa3 issuer rating to Illumina; outlook stable (Moodys)
09.03.21	Illumina, Inc. -- Moody's assigns a first-time Baa3 rating to Illumina; outlook stable (Moodys)
09.03.21	Illumina, Inc. -- Moody's assigns a first-time Baa3 rating to Illumina; outlook stable (Moodys)
05.03.21	Illumina and R-Pharm Secure Registration for Two Complete IVD Sequencing Platforms in Russia (Businesswire)
28.02.21	Februar 2021: Experten empfehlen Illumina-Aktie mehrheitlich zum Kauf (finanzen.net)
19.02.21	Illumina and the University Hospital of Tübingen Evaluate Potential of Whole Genome Sequencing to Improve Diagnosis of Full Range of Genetic Diseases (Businesswire)
10.02.21	Illumina to Webcast Upcoming Investor Conference Presentations (Businesswire)
08.02.21	Illumina Accelerator Invests in Nine Genomics Startups for Second Global Cycle (Businesswire)
04.02.21	Illumina Supports National Program to Evaluate Potential of Comprehensive Genomic Profiling in Late Stage Cancer Real-World Setting Across Belgium (Businesswire)
01.02.21	Illumina and Sequoia Capital China Partner to Launch Genomics Incubator in China (Businesswire)
27.01.21	Erste Schätzungen: Illumina legt die Bilanz zum abgelaufenen Quartal vor (finanzen.net)
25.01.21	Illumina to Announce Fourth Quarter & Full Year 2020 Financial Results on Thursday, February 11, 2021 (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

20.11.24		Mittwochshandel in New York: NASDAQ 100 liegt letztendlich im Minus
20.11.24		Schwacher Wochentag in New York: NASDAQ 100 in der Verlustzone
20.11.24		Schwacher Handel: NASDAQ 100 schwächelt mittags
20.11.24		Schwacher Wochentag in New York: NASDAQ 100 präsentiert sich zum Handelsstart schwächer
19.11.24		Börse New York in Grün: S&P 500 zum Ende des Dienstagshandels im Aufwind
18.11.24		Pluszeichen in New York: NASDAQ 100 zum Ende des Montagshandels in Grün
18.11.24		Börse New York in Grün: Börsianer lassen NASDAQ 100 nachmittags steigen
18.11.24		NASDAQ-Handel: NASDAQ 100 zeigt sich am Montagmittag fester

20.11.24

Mittwochshandel in New York: NASDAQ 100 liegt letztendlich im Minus

20.11.24

Schwacher Wochentag in New York: NASDAQ 100 in der Verlustzone

20.11.24

Schwacher Handel: NASDAQ 100 schwächelt mittags

20.11.24

Schwacher Wochentag in New York: NASDAQ 100 präsentiert sich zum Handelsstart schwächer

19.11.24

Börse New York in Grün: S&P 500 zum Ende des Dienstagshandels im Aufwind

18.11.24

Pluszeichen in New York: NASDAQ 100 zum Ende des Montagshandels in Grün